Merck KGaA - Company Profile
Powered by 
All the sales intelligence you need on Merck KGaA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Merck KGaA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Merck KGaA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View more- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
Business Description
Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company engaged in Life Science, Healthcare, and Electronics. The company operates in three primary industries: Life Science, which provides tools and services for scientific research; Healthcare, which develops and markets prescription drugs and biopharmaceuticals; and Electronics, which supplies materials for the semiconductor and display industries. In the US and Canada, the company operates as EMD Serono in the Biopharma business; as MilliporeSigma in the Life Science business; and as EMD Performance Materials in the Materials business.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Merck is focused on developing innovations that improve quality of life across the healthcare, life science, and electronics industries. The company invests in groundbreaking medicines and technologies, with a significant focus on cancer, multiple sclerosis, and infertility treatments. The company is leveraging internal discoveries and external partnerships to drive scientific breakthroughs and develop innovative therapies. The key initiatives include driving scientific breakthroughs in life sciences, developing innovative therapies in healthcare, and accelerating microchip development in electronics. The company is also enhancing its R&D processes by integrating sustainability criteria and collaborating with third parties. Its major projects include the M-Trust platform for product safety and traceability, the spin-out of EdiMembre, Inc for alternative protein technology, and strategic partnerships with Palantir Technologies and imec for AI data flows and microphysiological systems, respectively. Merck is advancing artificial intelligence (AI) in drug discovery, mRNA synthesis, and smart manufacturing technologies, while integrating sustainability into its R&D processes. The company focuses on AI through the usage of models to describe the phenomenon of intelligence on a high level of abstraction and building algorithms to solve cognitive tasks with a focus on unsupervised learning of invariant representations. Some of its pipeline products include pimicotinib for tenosynovial giant cell tumor, avelumab for metastatic urothelial carcinoma, cladribine for generalized myasthenia gravis, enpatoran for cutaneous lupus erythematosus, and cabamiquine for malaria, among others. Merck has approximately 12 R&D hubs strategically located across 65 countries globally. The company is involved in major technology alliances, including partnerships with Palantir for platforms like Syntropy and Athinia, which enable secure AI data flows and data sharing ecosystems. The company is also engaged in a strategic partnership with Siemens to foster transformative projects across its business sectors. In FY2025, the company spent EUR2,415 million on its R&D activities, which as a percentage of revenue stood at 11.4% and grew 6% YoY.
Business Segments
Overview
It supplies materials for the semiconductor and display industries and surface design. It also offers high-performance chips needed for applications including artificial intelligence (AI). Customers include manufacturers of logic, memory, and analog microchips. Technology fields include thin films, planarization, patterning lithography, patterning cleans, delivery systems and services, specialty gases, optronics, metrology and inspection, and intermolecular. The segment is segregated further into three categories, namely: Semiconductor Solutions, Optronics, and Surface Solutions. The Semiconductor Solutions business unit consists of the Thin Films, Formulations, Specialty Gases, and Delivery Systems & Services business fields. The Thin Films business field supplies solutions and products for its customers in the fields of dielectrics (organosilanes and spin-on dielectrics) and metallic materials. The Formulations business field offers lithography products such as photoresists, anti-reflective coatings, and materials for directed self-assembly (DSA). It also offers cleans and selective etch chemistries that help improve the patterning process. The Planarization business encompasses materials for chemical-mechanical planarization (CMP). The Specialty Gases business field provides high-purity gases for semiconductor manufacturing, used for precise deposition, doping, etching, and cleaning during wafer processing. The Delivery Systems & Services (DS&S) business field develops and installs reliable delivery equipment. The Optronics business unit controls light for imaging, processing, measurements, and inspection. It includes the businesses with liquid crystals (LC), display patterning materials (photoresists), materials for organic light-emitting diodes (OLED), and reactive mesogens. It also offers optical metrology equipment. The Surface Solutions business unit offers customers solutions that help them create functional and decorative surfaces of all kinds. Products are used in automotive coatings, cosmetics, and industrial applications. Its functional solutions serve many innovative applications, from dirt-repellent and easy-care surfaces to laser markings of plastic parts and cables. The segment's strategy is to be a leading partner in materials and material-related equipment and offer services for the electronics industry by maximizing added value for its customers with the company's Materials Intelligence.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Discovers, develops, manufactures and markets prescription drugs and biopharmaceuticals. It majorly focuses on the therapeutic areas of oncology, neurology, immunology, fertility, cardiovascular, metabolic, and endocrinological disorders. The segment's strategy is to increase its intake of external innovation in line with industry practice to bolster the company's pipeline with more attractive business opportunities. It also focuses to reinforce and expand the global presence, bringing the innovation of its pipeline to patients and growing the business in all major markets.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Encompasses business with tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, and the industrial sector. It offers a broad and deep product portfolio and global services as a contract development and manufacturing organization (CDMO), ranging from process development to commercialization. It also offers a wealth of expertise. The segment is segregated further into three categories, namely: Science & Lab Solutions, Process Solutions and Life Science Services. The Science & Lab Solutions business unit supports customers in the biotech and pharmaceutical industries, public authorities, scientific institutions, and other industrial markets. Products include reagents, consumables, devices, instruments, software, and services for research, production, and testing in addition to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. The Process Solutions business unit offers its services to biotech and pharma customers that focus on developing and manufacturing traditional and novel therapies. Products and services include filtration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing. The Life Science Services business unit manufactures traditional and novel modalities for biotech and pharmaceutical customers, including monoclonal antibodies, high-potency active pharmaceutical ingredients, antibody-drug conjugates, and viral and gene therapy products, as well as mRNA. The segment's strategy includes focusing on increasing sales and EBITDA pre by strengthening the focus on academic, biotech and pharma customers and establishing portfolio leadership. It also aims to improve our customer experience and drive operational excellence.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer